Article Versions Notes

Lottini T, Duranti C, Iorio J, Martinelli M, Colasurdo R, D’Alessandro FN, Buonamici M, Coppola S, Devescovi V, La Vaccara V, et al. Combination Therapy with a Bispecific Antibody Targeting the hERG1/β1 Integrin Complex and Gemcitabine in Pancreatic Ductal Adenocarcinoma. Cancers. 2023; 15(7):2013. https://doi.org/10.3390/cancers15072013

Lottini, Tiziano, Claudia Duranti, Jessica Iorio, Michele Martinelli, Rossella Colasurdo, Franco Nicolás D’Alessandro, Matteo Buonamici, Stefano Coppola, Valentina Devescovi, Vincenzo La Vaccara, and et al. 2023. "Combination Therapy with a Bispecific Antibody Targeting the hERG1/β1 Integrin Complex and Gemcitabine in Pancreatic Ductal Adenocarcinoma" Cancers 15, no. 7: 2013. https://doi.org/10.3390/cancers15072013

Lottini, T., Duranti, C., Iorio, J., Martinelli, M., Colasurdo, R., D’Alessandro, F. N., Buonamici, M., Coppola, S., Devescovi, V., La Vaccara, V., Coppola, A., Coppola, R., Lastraioli, E., & Arcangeli, A. (2023). Combination Therapy with a Bispecific Antibody Targeting the hERG1/β1 Integrin Complex and Gemcitabine in Pancreatic Ductal Adenocarcinoma. Cancers, 15(7), 2013. https://doi.org/10.3390/cancers15072013